A major advance in cancer research is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This vital tumor protector protein is frequently disabled in several types of tumors, resulting https://wildbookmarks.com/story22150691/vhh-fragments-reactivate-p53-the-potential-pathway-for-malignant-therapy